LFCR ($LFCR) Insider Trading & Smart Money Activity

LFCR · Drug Manufacturers - Specialty & Generic · Latest filing Jun 16, 2026

$LFCR has 1 analyst rating on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 0
Analyst ratings on file: 1

LFCR insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All LFCR insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 16, 2026	Analyst	Barrington Research	Reiterates to buy		PT $6.50		+5.8%	-7.5%			Read

1W / 1M / 6M = how LFCR moved from the trade or filing date.

Analyst ratings on LFCR

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 16, 2026	Barrington Research	Reiterates	buy	$6.50	+5.8%	-7.5%		Read

Other drug manufacturers - specialty & generic stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text